Evidence map›Paper›PMID 32251483›Full record

ArticlePLoS pathogens2020

Human cytomegalovirus IE2 drives transcription initiation from a select subset of late infection viral promoters by host RNA polymerase II.

Ming Li, Christopher B Ball, Geoffrey Collins, Qiaolin Hu, Donal S Luse, David H Price, Jeffery L Meier

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Human cytomegalovirus and neonatal infection.Current research in microbial sciences · 2024
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Virus, Exosome, and MicroRNA: New Insights into Autophagy.Advances in experimental medicine and biology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ming LiDepartments of Internal Medicine and Epidemiology, University of Iowa and Iowa City Veterans Affairs Health Care System, Iowa City, IA, United States of America.ORCID 0000-0003-0396-4078
Christopher B BallDepartment of Biochemistry, University of Iowa, Iowa City, IA, United States of America.ORCID 0000-0002-5983-1605
Geoffrey CollinsDepartment of Biochemistry, University of Iowa, Iowa City, IA, United States of America.
Qiaolin HuDepartments of Internal Medicine and Epidemiology, University of Iowa and Iowa City Veterans Affairs Health Care System, Iowa City, IA, United States of America.ORCID 0000-0001-6236-0261
Donal S LuseDepartment of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, United States of America.
David H PriceDepartment of Biochemistry, University of Iowa, Iowa City, IA, United States of America.
Jeffery L MeierDepartments of Internal Medicine and Epidemiology, University of Iowa and Iowa City Veterans Affairs Health Care System, Iowa City, IA, United States of America.ORCID 0000-0001-9491-1697
University of Iowa · USCleveland Clinic Lerner College of Medicine · US

Funding

RNA polymerase II elongation controlR35GM126908 · NIGMS · UNIVERSITY OF IOWA · PI PRICE, DAVID H · 2018 to 2022
$2.9M
The effect of nucleosomes on the earliest stages of RNA polymerase II transcriptionR01GM121428 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI Donal Luse · 2018 to 2026
$2.4M
Transcriptional Mechanisms Controlling HCMV InfectionR21AI130453 · NIAID · UNIVERSITY OF IOWA · PI MEIER, JEFFERY L, PRICE, DAVID H · 2018 to 2019
$347k
Mechanisms Regulating CytomegalovirusI01BX004434 · VA · IOWA CITY VA MEDICAL CENTER · PI JEFFERY L MEIER · 2019 to 2026
–
BLRD VA I01 BX004434NIAID NIH HHS R21 AI130453NIGMS NIH HHS R01 GM121428NIGMS NIH HHS R35 GM126908
6 · The paper itself

Abstract

Herpesvirus late promoters activate gene expression after viral DNA synthesis has begun. Alphaherpesviruses utilize a viral immediate-early protein to do this, whereas beta- and gammaherpesviruses primarily use a 6-member set of viral late-acting transcription factors (LTF) that are drawn to a TATT sequence in the late promoter. The betaherpesvirus, human cytomegalovirus (HCMV), produces three immediate-early 2 protein isoforms, IE2-86, IE2-60, IE2-40, late in infection, but whether they activate late viral promoters is unknown. Here, we quickly degrade the IE2 proteins in late infection using dTag methodology and analyze effects on transcription using customized PRO-Seq and computational methods combined with multiple validation methods. We discover that the IE2 proteins selectively drive RNA Pol II transcription initiation at a subset of viral early-late and late promoters common to different HCMV strains, but do not substantially affect Pol II transcription of the 9,942 expressed host genes. Most of the IE2-activated viral late infection promoters lack the TATT sequence bound by the HCMV UL87-encoded LTF. The HCMV TATT-binding protein is not mechanistically involved in late RNA expression from the IE2-activated TATT-less UL83 (pp65) promoter, as it is for the TATT-containing UL82 (pp71) promoter. While antecedent viral DNA synthesis is necessary for transcription from the late infection viral promoters, continued viral DNA synthesis is unnecessary. We conclude that in late infection the IE2 proteins target a distinct subset of HCMV early-late and late promoters for transcription initiation by RNA Pol II. Commencement of viral DNA replication renders the HCMV genome late promoters susceptible to late-acting viral transcription factors.

Indexed as

DNA ReplicationPromoter Regions, GeneticCytomegalovirusCytomegalovirus InfectionsDNA, ViralGene Expression Regulation, ViralHumansImmediate-Early ProteinsRNA Polymerase IITrans-ActivatorsTranscription Initiation, GeneticViral ProteinsVirus ReplicationDNA, ViralIE2 protein, CytomegalovirusImmediate-Early ProteinsRNA Polymerase IITrans-ActivatorsViral Proteins

Identifiers

PMID32251483
PMCPMC7162547
OpenAlexW3014110333

What Socratic holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.